Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 1
2004 10
2005 8
2006 10
2007 11
2008 13
2009 13
2010 13
2011 18
2012 22
2013 17
2014 28
2015 24
2016 25
2017 19
2018 11
2019 24
2020 18
2021 17
2022 15
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Results by year

Filters applied: . Clear all
Page 1
NTHL1 is a recessive cancer susceptibility gene.
Nurmi AK, Pelttari LM, Kiiski JI, Khan S, Nurmikolu M, Suvanto M, Aho N, Tasmuth T, Kalso E, Schleutker J, Kallioniemi A, Heikkilä P; FinnGen; Aittomäki K, Blomqvist C, Nevanlinna H. Nurmi AK, et al. Among authors: blomqvist c. Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.
Angiosarcoma in the breast: a population-based cohort from Sweden.
Olander S, Wennstig AK, Garmo H, Holmberg L, Nilsson G, Blomqvist C, Karlsson F, Wickberg Å, Wärnberg F, Sund M, Wadsten C. Olander S, et al. Among authors: blomqvist c. Br J Surg. 2023 Nov 9;110(12):1850-1856. doi: 10.1093/bjs/znad290. Br J Surg. 2023. PMID: 37708086
Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurement.
Faltinová M, Vehmanen L, Lyytinen H, Haanpää M, Hämäläinen E, Tiitinen A, Blomqvist C, Mattson J. Faltinová M, et al. Among authors: blomqvist c. Breast Cancer Res Treat. 2023 Oct;201(3):425-435. doi: 10.1007/s10549-023-07054-3. Epub 2023 Jul 25. Breast Cancer Res Treat. 2023. PMID: 37491651 Free PMC article. Clinical Trial.
Digital solution in the follow-up of early breast cancer a randomized study.
Mattson J, Peltola M, Poikonen-Saksela P, Hermanson T, Their J, Färkkilä N, Roine R, Blomqvist C. Mattson J, et al. Among authors: blomqvist c. Acta Oncol. 2023 May;62(5):513-521. doi: 10.1080/0284186X.2023.2212409. Epub 2023 May 16. Acta Oncol. 2023. PMID: 37190970 Clinical Trial.
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants.
Muranen TA, Morra A, Khan S, Barnes DR, Bolla MK, Dennis J, Keeman R, Leslie G, Parsons MT, Wang Q, Ahearn TU, Aittomäki K, Andrulis IL, Arun BK, Behrens S, Bialkowska K, Bojesen SE, Camp NJ, Chang-Claude J, Czene K, Devilee P; HEBON investigators; Domchek SM, Dunning AM, Engel C, Evans DG, Gago-Dominguez M, García-Closas M, Gerdes AM, Glendon G, Guénel P, Hahnen E, Hamann U, Hanson H, Hooning MJ, Hoppe R, Izatt L, Jakubowska A, James PA, Kristensen VN, Lalloo F, Lindeman GJ, Mannermaa A, Margolin S, Neuhausen SL, Newman WG, Peterlongo P, Phillips KA, Pujana MA, Rantala J, Rønlund K, Saloustros E, Schmutzler RK, Schneeweiss A, Singer CF, Suvanto M, Tan YY, Teixeira MR, Thomassen M, Tischkowitz M, Tripathi V, Wappenschmidt B, Zhao E, Easton DF, Antoniou AC, Chenevix-Trench G, Pharoah PDP, Schmidt MK, Blomqvist C, Nevanlinna H. Muranen TA, et al. Among authors: blomqvist c. NPJ Breast Cancer. 2023 May 12;9(1):37. doi: 10.1038/s41523-023-00546-x. NPJ Breast Cancer. 2023. PMID: 37173335 Free PMC article.
300 results